Systematic review of the economic impact of cerebral palsy
Section snippets
What does this paper add?
This review systematically documents and summarises the economic impacts of CP from literature that employed different analysis techniques, cost components, and settings. This review showed that there was a strong positive relationship between CP severity and expenditure. Significant costs were borne by families and the welfare system to facilitate school and community engagement. Facilitating participation for people with CP involves substantial expense. The cost burden of CP highlights the
Methods
Publications on the COI/BoD of CP were identified from Ovid Medline, Embase, CINHAL, PsyInfo, Econlit, Health Economic Evaluation Database (HEED) and NHS Economic Evaluation Database (NHS EED) in the Cochrane Library, using the following search terms: costs, health care cost, cost analysis, cost estimates, economic burden, cost-effectiveness, cost-benefit or economic evaluation and CP. Note that articles associated with cost-effectiveness analysis for CP interventions were also assessed but
Results
The search retrieved 917 publications, from which 101 full text reviews were undertaken of publications reporting health care costs, cost analysis; and economic evaluation. From this, a total of 22 relevant publications (including 5 conference abstracts without full text) on the economic burden of CP were included in this review (Fig. 1).
Costs were estimated by various approaches. Costs are generally reported either a “cost per person with CP” or as an “annual cost” for a target population.
Estimated lifetime costs
The Centres for Disease Control and Prevention (CDC) in the US determined national lifetime costs using a California birth cohort in 1992 (Centers for Disease C & Prevention, 1995). Total lifetime costs for CP were approximately US$4.1 billion (adjusted from the reported US$2.4 billion in 1992), which consisted of US$2.2 billion in medical, developmental and special education services and US$1.9 billion in productivity losses. The lifetime costs estimated were US$862,762 per new CP case (with
Cost of illness at a national level
A population-based analysis using the Taiwanese National Health Insurance database reported that children with CP spent an average of US$773 more on medical expenditure than children having other conditions associated with developmental delay (Chang et al., 2013) before the age of 6 years. This study found that medical expenses were higher if the children were boys, were aged 2–3 years old and were hospitalized.
The estimated annual costs of CP in Australia were US$1.5 billion (0.14% of GDP),
Cost of illness in selected samples
An Australian cohort study involving 155 children with CP aged 30–36 months corrected age, found a positive correlation between average traditional therapy cost per child and the degree of gross motor function (Pareezer et al., 2012). The Gross Motor Function Classification System (GMFCS) was used to classify the severity of gross motor function where children with GMFCS 1 have least mobility impairment through to GMFCS V with the most severe mobility impairment. Average total costs for
Indirect economic impacts on the communities and carers
In addition to the healthcare system, the cost impact of CP on unpaid family carers, communities, and the welfare and education systems is significant. Mothers of children with disability reported poorer health, lower family income and lower workforce participation, even though the participants had higher education (Bourke-Taylor et al., 2011). This Australian study found 82% of mothers wanted and needed to work, but were prevented from work participation due to a wide range of issues related
Discussion
The review has highlighted significant economic impacts associated with CP in many countries and settings. If used carefully, such COI information can assist decision makers in their day-to-day decisions. The lifetime cost, for example, can be useful for providing the potential cost offsets from the prevention of new cases of CP. The annual costs of all existing cases, on the other hand, can be useful for financial planning and management purposes. Specific population costs for target groups,
Acknowledgements
This literature review was funded by the Victoria Managed Insurance Authority (VMIA). Special thanks to chief investigators of the Centre of Research Excellence in Cerebral Palsy for comments and feedbacks on this work. Any opinions, findings, and conclusions or recommendations expressed in this paper are those of the author(s) and do not necessarily reflect the views of the VMIA. The authors have no conflicts of interest to declare.
References (30)
- et al.
Parent caregiver-related predictors of health care service utilization by children with cerebral palsy enrolled in Medicaid
Journal of Pediatric Health Care
(2002) - et al.
The economic burden in children with developmental delay: A nationwide population-based case-control study
European Journal of Paediatric Neurology
(2013) - et al.
Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children
Research in Developmental Disabilities
(2012) - et al.
Prevalence and lifetime healthcare cost of cerebral palsy in South Korea
Health Policy
(2011) - et al.
A preliminary study into the economic burden of cerebral palsy in China
Health Policy
(2008) The economic impact of cerebral palsy in Australia in 2007
Access Economics pty Limited for Cerebral palsy Australia
(2008)Financial assistance for carers
(2016)- et al.
Supporting young adults with hemiplegia: Services and costs
Health and Social Care in the Community
(2001) - et al.
Barriers to maternal workforce participation and relationship between paid work and health
Journal of Intellectual Disability Research
(2011) - et al.
Young children with cerebral palsy: Families self-reported equipment needs and out-of-pocket expenditure
Child: Care, Health and Development
(2014)
Complementary, alternative, and mainstream service use among families with young children with multiple disabilities: Family costs to access choices
Physical and Occupational Therapy in Pediatrics
Economic costs of birth defects and cerebral palsy-United States, 1992
MMWR - Morbidity and Mortality Weekly Report
Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003
MMWR - Morbidity and Mortality Weekly Report
The economic value of informal care in Australia in 2015
A review of the incidence and prevalence, types and aetiology of childhood cerebral palsy in resource-poor settings
Annals of Tropical Paediatrics
Cited by (47)
Potentially Preventable Hospitalizations Among Adults With Pediatric-Onset Disabilities
2022, Mayo Clinic ProceedingsCitation Excerpt :However, mainly due to our disintegrated systems of care in the United States, transition to these centers is arduous.40 Adults with CP/SB are at a greater risk for developing secondary comorbid conditions and preventable adverse health events.11,12,41 These adult health care centers often lack a multidisciplinary team of primary care doctors and specialists who are critical to the care of adults with CP/SB.27
MicroRNA-21-5p agomir inhibits apoptosis of oligodendrocyte precursor cell and attenuates white matter injury in neonatal rats
2022, Brain Research BulletinCitation Excerpt :Finally, we believe that miR-21-5p can have an antiapoptotic role by downregulating the expression of its target gene PTEN, upregulating the phosphorylation of p-Akt and inhibiting the production of related apoptotic proteins. Despite recent advances in neonatal rescue technologies, WMI is a prevalent occurrence in preterm newborns, typically accompanied with short- or long-term neurological abnormalities, a poor prognosis, and a lack of effective therapeutic preventative strategies, putting a huge cost on families and society (Amankwah et al., 2020; Tonmukayakul et al., 2018). Chronic failure during myelination, which also impedes the development of OPCs in white matter areas, is regarded to be the most noticeable neuroanatomical hallmark of WMI in preterm newborns (Miew et al., 2014).
Immunological effects of cerebral palsy and rehabilitation exercises in children
2021, Brain, Behavior, and Immunity - HealthCitation Excerpt :CP imposes a huge financial burden on both parents and society. In the US, the estimated total lifetime cost per CP patient was $1.2 million in 2004, and approximately the same lifetime cost was reported in Denmark in 2009 (Tonmukayakul et al., 2018). CP manifests with features of movement disorders due to non-progressive brain lesions during the antenatal, perinatal, or early postnatal period.
Diagnosing newborns with suspected mitochondrial disorders: an economic evaluation comparing early exome sequencing to current typical care
2021, Genetics in MedicineCitation Excerpt :We used CP as a proxy for long-term costs for newborns with severe MitD, under the assumption that postdischarge costs associated with CP are like those of MitD. The direct costs associated with CP are calculated from published literature, per year of life (Table 1, Appendix Table 2).21-24 All costs are adjusted to 2019 US dollars, and foreign costs adjusted using medical goods purchasing power parity (Appendix Table 3).25